SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective
Authors
Keywords
-
Journal
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2020-04-27
DOI
10.1080/07391102.2020.1761882
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China
- (2020) David S. Hui et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
- (2020) Hussin A. Rothan et al. JOURNAL OF AUTOIMMUNITY
- Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel
- (2020) Isaac I Bogoch et al. JOURNAL OF TRAVEL MEDICINE
- Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
- (2020) Abdo A. Elfiky LIFE SCIENCES
- Remdesivir as a possible therapeutic option for the COVID-19
- (2020) Jaffar A. Al-Tawfiq et al. Travel Medicine and Infectious Disease
- Peptide-like and small-molecule inhibitors against Covid-19
- (2020) Suyash Pant et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin
- (2020) Anwarul Hasan et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations
- (2020) I. Aanouz et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
- (2020) Subramanian Boopathi et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19
- (2020) Nisha Muralidharan et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
- (2020) Ammar D. Elmezayen et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study
- (2020) Maryam Enayatkhani et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)
- (2020) Phulen Sarma et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- COVID-19 spike-host cell receptor GRP78 binding site prediction
- (2020) Ibrahim M. Ibrahim et al. JOURNAL OF INFECTION
- Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
- (2020) Abdo A. Elfiky LIFE SCIENCES
- Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
- (2019) Robert N. Kirchdoerfer et al. Nature Communications
- Recognition of the gluconeogenic enzyme, Pck1, via the Gid4 E3 ligase: An in silico perspective
- (2019) Alaa M. Ismail et al. JOURNAL OF MOLECULAR RECOGNITION
- Molecular dynamics and docking reveal the potency of novel GTP derivatives against RNA dependent RNA polymerase of genotype 4a HCV
- (2019) Abdo A. Elfiky et al. LIFE SCIENCES
- Molecular docking revealed the binding of nucleotide/side inhibitors to Zika viral polymerase solved structures
- (2018) A. A. Elfiky et al. SAR AND QSAR IN ENVIRONMENTAL RESEARCH
- Novel Guanosine Derivatives as Anti-HCV NS5b polymerase: A QSAR and Molecular Docking Study
- (2018) Abdo A Elfiky Medicinal Chemistry
- Applications of computer-aided approaches in the development of hepatitis C antiviral agents
- (2017) Aravindhan Ganesan et al. Expert Opinion on Drug Discovery
- Molecular modeling and docking revealed superiority of IDX-184 as HCV polymerase inhibitor
- (2017) Abdo A Elfiky et al. Future Virology
- Zika virus: novel guanosine derivatives revealed strong binding and possible inhibition of the polymerase
- (2017) Abdo A Elfiky Future Virology
- Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses
- (2017) Abdo A. Elfiky et al. JOURNAL OF MEDICAL VIROLOGY
- Molecular dynamics simulation revealed binding of nucleotide inhibitors to ZIKV polymerase over 444 nanoseconds
- (2017) Abdo A. Elfiky et al. JOURNAL OF MEDICAL VIROLOGY
- Zika viral polymerase inhibition using anti-HCV drugs both in market and under clinical trials
- (2016) Abdo A. Elfiky JOURNAL OF MEDICAL VIROLOGY
- IDX-184 is a superior HCV direct-acting antiviral drug: a QSAR study
- (2016) Abdo A. Elfiky et al. MEDICINAL CHEMISTRY RESEARCH
- Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
- (2015) Jasper F. W. Chan et al. CLINICAL MICROBIOLOGY REVIEWS
- PLIP: fully automated protein–ligand interaction profiler
- (2015) Sebastian Salentin et al. NUCLEIC ACIDS RESEARCH
- PubChem Substance and Compound databases
- (2015) Sunghwan Kim et al. NUCLEIC ACIDS RESEARCH
- SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information
- (2014) Marco Biasini et al. NUCLEIC ACIDS RESEARCH
- Molecular Modeling Comparison of the Performance of NS5b Polymerase Inhibitor (PSI-7977) on Prevalent HCV Genotypes
- (2013) Abdo A. Elfiky et al. PROTEIN JOURNAL
- Structural properties of metal-free apometallothioneins
- (2012) Kelly L. Summers et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started